[{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604 921 1810", "fax": "604 921 1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the\nclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams FCPA, M.D.", "age": 69, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2025, "totalPay": 711724, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 51, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 535361, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2025, "totalPay": 447547, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2025, "totalPay": 493048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 78, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2025, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.01, "open": 9.1763, "dayLow": 8.95, "dayHigh": 9.2657, "regularMarketPreviousClose": 9.01, "regularMarketOpen": 9.1763, "regularMarketDayLow": 8.95, "regularMarketDayHigh": 9.2657, "payoutRatio": 0.0, "beta": 1.917, "forwardPE": -22.948719, "volume": 17507, "regularMarketVolume": 17507, "averageVolume": 68757, "averageVolume10days": 50560, "averageDailyVolume10Day": 50560, "bid": 6.7, "ask": 11.52, "bidSize": 2, "askSize": 2, "marketCap": 16922256, "fiftyTwoWeekLow": 3.5, "fiftyTwoWeekHigh": 98.2, "allTimeHigh": 1563.518, "allTimeLow": 3.5, "fiftyDayAverage": 10.6906, "twoHundredDayAverage": 21.24405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6057428, "profitMargins": 0.0, "floatShares": 1674529, "sharesOutstanding": 1883906, "sharesShort": 123407, "sharesShortPriorMonth": 129157, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0655, "heldPercentInsiders": 0.02338, "heldPercentInstitutions": 0.047519997, "shortRatio": 2.7, "shortPercentOfFloat": 0.0656, "impliedSharesOutstanding": 1890755, "bookValue": 5.296, "priceToBook": 1.6899546, "lastFiscalYearEnd": 1753920000, "nextFiscalYearEnd": 1785456000, "mostRecentQuarter": 1761868800, "netIncomeToCommon": -28707256, "trailingEps": -33.87, "forwardEps": -0.39, "lastSplitFactor": "1:10", "lastSplitDate": 1756080000, "enterpriseToEbitda": -0.2, "52WeekChange": 0.70000005, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 8.95, "targetHighPrice": 150.0, "targetLowPrice": 150.0, "targetMeanPrice": 150.0, "targetMedianPrice": 150.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 10175972, "totalCashPerShare": 5.402, "ebitda": -30268288, "totalDebt": 0, "quickRatio": 3.42, "currentRatio": 3.42, "returnOnAssets": -1.61642, "returnOnEquity": -4.44067, "freeCashflow": -18512680, "operatingCashflow": -28920240, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1331731800000, "corporateActions": [], "postMarketTime": 1766183434, "regularMarketTime": 1766178000, "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.665931, "regularMarketPrice": 8.95, "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "marketState": "CLOSED", "postMarketChangePercent": 2.2346349, "postMarketPrice": 9.15, "postMarketChange": 0.19999981, "regularMarketChange": -0.0600004, "regularMarketDayRange": "8.95 - 9.2657", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 68757, "fiftyTwoWeekLowChange": 5.45, "fiftyTwoWeekLowChangePercent": 1.5571429, "fiftyTwoWeekRange": "3.5 - 98.2", "fiftyTwoWeekHighChange": -89.25, "fiftyTwoWeekHighChangePercent": -0.9088595, "fiftyTwoWeekChangePercent": 70.00001, "dividendDate": 1577923200, "earningsTimestampStart": 1749758400, "earningsTimestampEnd": 1750104000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -33.87, "epsForward": -0.39, "fiftyDayAverageChange": -1.7406006, "fiftyDayAverageChangePercent": -0.16281597, "twoHundredDayAverageChange": -12.294049, "twoHundredDayAverageChangePercent": -0.57870555, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "cryptoTradeable": false, "displayName": "BriaCell Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]